SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test
At DNA Labs UAE, we offer the SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test. This test is designed to diagnose individuals who may be affected by glycosylation disorder type 2M, a rare genetic disorder associated with mutations in the SLC35A2 gene.
Test Details
Glycosylation disorder type 2M is a condition that affects the glycosylation process, which involves the attachment of sugar molecules to proteins and lipids. Mutations in the SLC35A2 gene can impair this process, leading to a range of symptoms and health problems.
Our SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously. This advanced sequencing technology allows us to identify mutations or variants in the SLC35A2 gene that may be responsible for the disorder.
Sample Collection
To perform this test, we require a DNA sample. This can be obtained through a blood sample, extracted DNA, or one drop of blood on an FTA card. Our expert technicians will handle the sample with utmost care to ensure accurate results.
Report Delivery
After sample collection, the DNA is sequenced using NGS technology. The entire process typically takes 3 to 4 weeks. Once the analysis is complete, we will provide you with a detailed report containing the results of the test.
Benefits of the Test
By identifying specific mutations or variants in the SLC35A2 gene, our SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test can help confirm a diagnosis of glycosylation disorder type 2M. This information is crucial for understanding the underlying cause of the disorder, predicting the course of the disease, and guiding treatment decisions.
Consultation and Cost
It is important to note that NGS genetic testing may not be available at all healthcare facilities. Therefore, a referral to a specialized genetic testing laboratory like DNA Labs UAE may be required. The cost and insurance coverage for this test can vary, so we recommend consulting with a healthcare professional or genetic counselor to discuss the options and potential implications of testing.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to learn more about our SLC35A2 Gene Glycosylation Disorder Type 2M Genetic Test and how it can help you.
| Test Name | SLC35A2 Gene Glycosylation disorder type 2M Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC35A2 Gene Glycosylation disorder type 2M NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2M |
| Test Details |
The SLC35A2 gene is associated with a rare genetic disorder called glycosylation disorder type 2M (also known as congenital disorder of glycosylation type 2M or CDG2M). This disorder affects the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Mutations in the SLC35A2 gene can lead to impaired glycosylation, resulting in a range of symptoms and health problems. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of glycosylation disorder type 2M, NGS genetic testing can be used to identify mutations or variants in the SLC35A2 gene that may be responsible for the disorder. The NGS genetic test for glycosylation disorder type 2M involves obtaining a DNA sample, typically through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology, which can detect changes in the SLC35A2 gene sequence. These changes can include small genetic mutations, deletions, insertions, or duplications. By identifying specific mutations or variants in the SLC35A2 gene, NGS genetic testing can help confirm a diagnosis of glycosylation disorder type 2M. This information can be useful for understanding the underlying cause of the disorder, predicting the course of the disease, and guiding treatment decisions. It is important to note that NGS genetic testing may not be available at all healthcare facilities and may require a referral to a specialized genetic testing laboratory. Additionally, the cost and insurance coverage for NGS genetic testing can vary, so it is advisable to consult with a healthcare professional or genetic counselor to discuss the options and potential implications of testing. |
